Cargando…
THU543 Acquired Resistance To CDK4/6 Inhibitors Is Associated With Upregulated IGF1R And IR Signaling
Disclosure: S.L. Gerhardt: None. C. Baar: None. I. Johnson: None. D. Sachdev: None. The most common subtype of breast cancer is hormone receptor-positive (HR+). While these patients are successfully treated with endocrine therapies (ET), over 30% of patients develop resistance and require other ther...
Autores principales: | Gerhardt, Summer Louise, Baar, Courtney, Johnson, Ivy, Sachdev, Deepali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555367/ http://dx.doi.org/10.1210/jendso/bvad114.2169 |
Ejemplares similares
-
THU502 CYR61, A Member Of The CCN Protein Family, Regulates IGF1 In Metastatic Prostate Cancer
por: Ortiz Hernandez, Greisha L, et al.
Publicado: (2023) -
THU553 Anti-tumor Effect Of Rosiglitazone Via Upregulating 15-PDGH In Prolactin Secreting Adenoma
por: Kang, Chan Woo, et al.
Publicado: (2023) -
THU560 Serum miRNA-483 As A Diagnostic And Therapeutic Marker Of IGF-II-producing Non-islet Cell Tumor Hypoglycemia (NICTH)
por: Okazaki-Hada, Mikiko, et al.
Publicado: (2023) -
THU516 An Unusual Neck Mass
por: Rios, Paola, et al.
Publicado: (2023) -
ODP543 Chemotherapy-induced extracellular HSP70 enhances pro-tumorigenic effects of macrophages in breast cancers.
por: Yamaguchi, Mio, et al.
Publicado: (2022)